Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer

NCT06809374 is registered in ClinicalTrials.gov with Kochi University as lead sponsor.

NCT NCT06809374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06809374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer
Lead sponsor
Kochi University
Phase
Observational
Overall status
Completed
Start date
January 1, 2015
Completion date
December 31, 2024
Enrollment
100 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer resectable